Location

Please check the individual session for location or broadcast availability.  

Frequency

Weekly

Series Director

Nghia Nguyen, MD

Target Audience and Needs

Pathologists, residents, and medical students need to be regularly updated with most recent techniques and guidelines for the diagnosis and management of benign and malignant hematologic disease in order to improve patient outcomes.

Educational Methods

Educational methods will include case presentations and panel discussions.

Objectives

At the conclusion of the sessions, the participants should be able to:

• Identify and interpret pertinent morphologic and clinical features of benign and malignant hematologic disease.
• Incorporate the most updated techniques in diagnosing benign and malignant hematologic disease.
• Determine the impact of pathologic diagnosis on treatment decisions by oncologists.
• Summarize new discoveries in hematologic diseases and implement them appropriately in clinical practice to improve diagnosis and treatment outcomes.

Evaluation

Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Baylor College of Medicine and The University of Texas Health Science Center at Houston. Baylor College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator 

Virginia Green
Virginia.Green@uth.tmc.edu
713-500-5376